| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | L929/A |
|---|
| Description | This Adriamycin-resistant cell line has been developed by exposure of the parent L929 murine fibroblast cell line to increasing concentrations of doxorubicin in-vitro. L929/A cells can be used in the development of novel anti-cancer treatments. Resistance can be circumvented by modulating agents such as verapamil and quinine. The parent cell line L929 was derived from normal subcutaneous areolar adipose tissue. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | CSC-C9505J |
|---|
| Price | |
|---|
| Order / More Info | L929/A from CREATIVE BIOARRAY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|